Research
Print page Print page
Switch language
Hvidovre Hospital - a part of Copenhagen University Hospital
Published

ZMYND11 variants are a novel cause of centrotemporal and generalised epilepsies with neurodevelopmental disorder

Research output: Contribution to journalJournal articlepeer-review

DOI

  1. Clinical and molecular delineation of PUS3-associated neurodevelopmental disorders

    Research output: Contribution to journalJournal articlepeer-review

  2. Tenorio syndrome: description of 14 novel cases and review of the clinical and molecular features

    Research output: Contribution to journalReviewpeer-review

  1. Clinical and molecular delineation of PUS3-associated neurodevelopmental disorders

    Research output: Contribution to journalJournal articlepeer-review

  2. NEXMIF encephalopathy: an X-linked disorder with male and female phenotypic patterns

    Research output: Contribution to journalJournal articlepeer-review

  3. Infantile spasmer

    Research output: Contribution to journalJournal articlepeer-review

  • Stephanie Oates
  • Michael Absoud
  • Sushma Goyal
  • Sophie Bayley
  • Jennifer Baulcomb
  • Annemarie Sims
  • Amy Riddett
  • Katrina Allis
  • Charlotte Brasch-Andersen
  • Meena Balasubramanian
  • Renkui Bai
  • Bert Callewaert
  • Ulrike Hüffmeier
  • Diana Le Duc
  • Maximilian Radtke
  • Christian Korff
  • Joanna Kennedy
  • Karen Low
  • Rikke S Møller
  • Jens Erik Klint Nielsen
  • Bernt Popp
  • Lina Quteineh
  • Gitte Rønde
  • Bitten Schönewolf-Greulich
  • Amelle Shillington
  • Matthew Rg Taylor
  • Emily Todd
  • Pernille M Torring
  • Zeynep Tümer
  • Georgia Vasileiou
  • T Michael Yates
  • Christiane Zweier
  • Richard Rosch
  • M Albert Basson
  • Deb K Pal
View graph of relations

ZMYND11 is the critical gene in chromosome 10p15.3 microdeletion syndrome, a syndromic cause of intellectual disability. The phenotype of ZMYND11 variants has recently been extended to autism and seizures. We expand on the epilepsy phenotype of 20 individuals with pathogenic variants in ZMYND11. We obtained clinical descriptions of 16 new and nine published individuals, plus detailed case history of two children. New individuals were identified through GeneMatcher, ClinVar and the European Network for Therapies in Rare Epilepsy (NETRE). Genetic evaluation was performed using gene panels or exome sequencing; variants were classified using American College of Medical Genetics (ACMG) criteria. Individuals with ZMYND11 associated epilepsy fell into three groups: (i) atypical benign partial epilepsy or idiopathic focal epilepsy (n = 8); (ii) generalised epilepsies/infantile epileptic encephalopathy (n = 4); (iii) unclassified (n = 8). Seizure prognosis ranged from spontaneous remission to drug resistant. Neurodevelopmental deficits were invariable. Dysmorphic features were variable. Variants were distributed across the gene and mostly de novo with no precise genotype-phenotype correlation. ZMYND11 is one of a small group of chromatin reader genes associated in the pathogenesis of epilepsy, and specifically ABPE. More detailed epilepsy descriptions of larger cohorts and functional studies might reveal genotype-phenotype correlation. The epileptogenic mechanism may be linked to interaction with histone H3.3.

Original languageEnglish
JournalClinical Genetics
Volume100
Issue number4
Pages (from-to)412-429
Number of pages18
ISSN0009-9163
DOIs
Publication statusPublished - Oct 2021

Bibliographical note

© 2021 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd.

    Research areas

  • antiepileptic drug, autism, bromodomain, comorbidity, EEG, epigenetic, histone H3.3, seizure

ID: 67846977